Literature DB >> 3942513

Dose-response relationship of propranolol in the treatment of essential tremor.

W C Koller.   

Abstract

The effect of doses of propranolol hydrochloride, 80 to 800 mg/day, was investigated in 15 patients with essential tremor. The dose was increased by 80 mg weekly. Tremor was recorded by an accelerometer and its amplitude and frequency was determined by spectral analysis. Serum propranolol level was measured by radioreceptor assay. Tremor control varied greatly from complete suppression at 80 mg/day to no reduction at 800 mg/day. Mean serum propranolol levels increased with increasing dosage, but they did not correlate with tremor suppression. Five patients did not tolerate doses higher than 640 mg/day. Maximum tremor suppression occurred within a dose range between 160 and 320 mg/day. Higher doses did not cause additional tremor reduction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942513     DOI: 10.1001/archneur.1986.00520010038018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  14 in total

1.  Essential Tremor.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 2.  Differential diagnosis of common tremor syndromes.

Authors:  R Bhidayasiri
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 3.  Transducer-based evaluation of tremor.

Authors:  Dietrich Haubenberger; Giovanni Abbruzzese; Peter G Bain; Nin Bajaj; Julián Benito-León; Kailash P Bhatia; Günther Deuschl; Maria João Forjaz; Mark Hallett; Elan D Louis; Kelly E Lyons; Tiago A Mestre; Jan Raethjen; Maria Stamelou; Eng-King Tan; Claudia M Testa; Rodger J Elble
Journal:  Mov Disord       Date:  2016-06-06       Impact factor: 10.338

4.  Assessing tremor severity.

Authors:  P G Bain; L J Findley; P Atchison; M Behari; M Vidailhet; M Gresty; J C Rothwell; P D Thompson; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

Review 5.  Management of essential tremor.

Authors:  Theresa A Zesiewicz; Elmyra Encarnacion; Robert A Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

6.  The Pharmacotherapeutic Landscape for Essential Tremor: Quantifying the Level of Unmet Need From a Patient and Epidemiologic Perspective.

Authors:  Elan D Louis
Journal:  Clin Neuropharmacol       Date:  2022-06-11       Impact factor: 1.379

Review 7.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Propranolol and propranolol-LA in essential tremor: a double blind comparative study.

Authors:  L Cleeves; L J Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

9.  Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia.

Authors:  Giulia Paparella; Gina Ferrazzano; Antonio Cannavacciuolo; Francesco Cogliati Dezza; Giovanni Fabbrini; Matteo Bologna; Alfredo Berardelli
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

Review 10.  Pharmacotherapy of essential tremor.

Authors:  Peter Hedera; František Cibulčík; Thomas L Davis
Journal:  J Cent Nerv Syst Dis       Date:  2013-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.